BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28053101)

  • 1. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.
    Johnson A; Chen LM; Winne E; Santana W; Metcalfe MG; Mateu-Petit G; Ridenour C; Hossain MJ; Villanueva J; Zaki SR; Williams TL; Cox NJ; Barr JR; Donis RO
    PLoS One; 2015; 10(6):e0128982. PubMed ID: 26068666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
    Hussain S; Turnbull ML; Pinto RM; McCauley JW; Engelhardt OG; Digard P
    J Gen Virol; 2019 Jul; 100(7):1079-1092. PubMed ID: 31169484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region.
    Cobbin JC; Ong C; Verity E; Gilbertson BP; Rockman SP; Brown LE
    J Virol; 2014 Aug; 88(16):8971-80. PubMed ID: 24872588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain Using an Engineered High-Fidelity Viral Polymerase.
    Mori K; Ohniwa RL; Takizawa N; Naito T; Saito M
    J Virol; 2021 May; 95(12):. PubMed ID: 33827947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
    Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
    J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M; de Jonge J; Laue M; Wolff T
    Vaccine; 2011 Jul; 29(32):5153-62. PubMed ID: 21624413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk.
    Zhang W; Xue T; Wu X; Zhang P; Zhao G; Peng D; Hu S; Wang X; Liu X; Liu W; Liu X
    Vaccine; 2011 Oct; 29(45):8032-41. PubMed ID: 21864614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein.
    Wanitchang A; Kramyu J; Jongkaewwattana A
    Virus Res; 2010 Jan; 147(1):145-8. PubMed ID: 19879908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus.
    Cobbin JC; Verity EE; Gilbertson BP; Rockman SP; Brown LE
    J Virol; 2013 May; 87(10):5577-85. PubMed ID: 23468502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
    Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
    Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
    Ramanunninair M; Le J; Onodera S; Fulvini AA; Pokorny BA; Silverman J; Devis R; Arroyo JM; He Y; Boyne A; Bera J; Halpin R; Hine E; Spiro DJ; Bucher D
    PLoS One; 2013; 8(6):e65955. PubMed ID: 23776579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.
    Naito T; Shirai K; Mori K; Muratsu H; Ushirogawa H; Ohniwa RL; Hanada K; Saito M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peculiarity of reassortment of current wild type influenza viruses with master donor viruses for live influenza vaccine].
    Kiseleva IV; Bazhenova EA; Larionova NV; Fedorova EA; Dubrovina IA; Isakova-Sivak IN; Rudenko LG
    Vopr Virusol; 2013; 58(5):26-31. PubMed ID: 24640168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
    Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.